Genital ulcer disease: current challenges and perspectives
DOI:
https://doi.org/10.14739/2310-1210.2025.3.322455Keywords:
genital ulcer disease, genital herpes, syphilis, chancroid, lymphogranuloma venereum, donovanosisAbstract
Aim. To analyze the role of etiological factors of genital ulcer disease based on data from professional literature and to develop proposals for improving diagnostic algorithms, as well as a syndromic approach to treatment and prevention, in particular, regarding current trends in world medical practice.
Materials and methods. Full-text articles were searched and analyzed in Google Scholar, Scopus, PubMed, and Web of Science databases. The search was performed using the following key terms: genital ulcer disease, genital herpes, syphilis, chancroid, lymphogranuloma venereum, donovanosis. Statistical data from the European Center for Disease Prevention and Control and the Centers for Disease Control and Prevention in the United States were also used.
Results. The World Health Organization pays considerable attention to sexually transmitted diseases and more specifically discusses the effective management and treatment of genital ulcers. The main causes of genital ulcers are infections caused by five major pathogens: herpes simplex virus type 2, syphilis, chancroid, donovanosis and lymphogranuloma venereum. According to recent studies, herpes simplex virus type 2 and syphilis remain the leading pathogens among infections that cause genital ulcers, but their role differs depending on the region and socioeconomic factors. The most important among these pathogens are herpes viruses due to the ability to cause recurrent and lifelong infection that are perhaps the main cause of genital ulcers. Infections such as chancroid and donovanosis are gradually decreasing in prevalence even in regions where they were more common in the past owing to changes in sexual behavior and improved access to modern means of prevention.
Conclusions. For effective treatment and diagnosis of genital ulcer disease and associated asymptomatic urogenital infections, it is important to improve diagnostic algorithms that will allow to identify the causative agents accurately and apply a comprehensive approach to treatment. An important area is the development of vaccines that will provide long-term immunity against major pathogens, in particular herpes simplex viruses and lymphogranuloma venereum, and thus will help to increase the protection of populations as well as reduce recurrences and antimicrobial resistance.
References
World Health Organization. Herpes Simplex Virus: Global Prevalence and Impact [Internet]. Geneva: WHO; [cited 2025 Jan 25]. Available from: https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus
European Centre for Disease Prevention and Control. Syphilis – Annual Epidemiological Report 2022. 2024 [cited 2025 Jan 14]; Available from: https://www.ecdc.europa.eu/en/publications-data/syphilis-annual-epidemiological-report-2022
World Health Organization. Syphilis. Geneva: WHO; 2024 May 21 [cited 2025 Jan 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/syphilis
Elflein J. Chancroid rate of reported cases U.S. 1950-2023 [Internet]. Statista. 2024 Feb 2 [cited 2025 Jan 14]. Available from: https://www.statista.com/statistics/626946/rate-of-cases-of-chancroid-in-the-us/
European Centre for Disease Prevention and Control. Annual Epidemiological Report for 2022 [Internet]. Europa.eu. 2024 [cited 2025 Jan 14]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/lymphogranuloma-venereum-annual-epidemiological-report-2022_0.pdf
Ayoade FO, Bronze MS. Herpes Simplex Clinical Presentation. Medscape. [Internet]. [cited 2025 Jan 25]. Available from: https://emedicine.medscape.com/article/218580-clinical
GlobalData Healthcare. As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech [Internet]. Clinical Trials Arena; 2024 Sep 25 [cited 2025 Jan 9]. Available from: https://www.clinicaltrialsarena.com/analyst-comment/gsk-hsv-vaccine-moderna-biontech/?cf-view
Álvarez DM, Castillo E, Duarte LF, Arriagada J, Corrales N, Farías MA, et al. Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection. Front Microbiol. 2020;11:139. doi: https://doi.org/10.3389/fmicb.2020.00139
Kaye KM. Herpes Simplex Infections. In: Porter RE. The Merck Manual of Diagnosis and Therapy. Rahway, NJ: Merck & Co Inc; 2023.
World Health Organization. Sexually Transmitted Infections Treatment Guidelines, 2021: Chlamydia trachomatis. Geneva: WHO; 2024 May 21 [cited 2025 Jan 25]. Available from: https://www.cdc.gov/std/treatment-guidelines/chlamydia.htm#print
Centers for Disease Control and Prevention. Chlamydial infections [Internet]. Cdc.gov. 2022 [cited 2025 Jan 14]. Available from: https://www.cdc.gov/std/treatment-guidelines/chlamydia.htm
Belda Junior W. Donovanosis. An Bras Dermatol. 2020;95(6):675-83. doi: https://doi.org/10.1016/j.abd.2020.07.002
Santhakumar S. Donovanosis: Definition, causes, symptoms, treatment [Internet]. Medicalnewstoday.com. 2022 [cited 2025 Jan 25]. Available from: https://www.medicalnewstoday.com/articles/flesh-eating-std-donovanosis
Bayram JD, Malik M. Gynecologic Infections. In: Emergency Medicine: Clinical Essentials, 2nd ed. Elsevier; 2012. p. 1097-1113.e1. doi: https://doi.org/10.1016/B978-1-4377-3548-2.00126-9
Santiago-Wickey JN, Crosby B. Granuloma Inguinale. [Updated 2023 Mar 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513306/
Centers for Disease Control and Prevention. Granuloma inguinale (donovanosis) [Internet]. Cdc.gov. 2021 [cited 2025 Jan 14]. Available from: https://www.cdc.gov/std/treatment-guidelines/donovanosis.htm
Centers for Disease Control and Prevention (CDC). Chancroid [Internet]. Cdc.gov. 2021 [cited 2025 Jan 14]. Available from: https://www.cdc.gov/std/treatment-guidelines/chancroid.htm
Guidelines for the management of symptomatic sexually transmitted infections [Internet]. Geneva: World Health Organization; 2021 Jun. 10, GENITAL ULCER DISEASE SYNDROME. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572660/
Kopkin R, Grenvik JM, Chiweza C, Iwuh I, Wilkinson J. Syndromic Treatment of STIs in Low-income Countries is Inadequate: Current Threats and Future Directions. Clin Obstet Gynecol. 2022;65(4):717-32. doi: https://doi.org/10.1097/GRF.0000000000000714
Bellizzi A, Çakır S, Donadoni M, Sariyer R, Liao S, Liu H, et al. Suppression of HSV-1 infection and viral reactivation by CRISPR-Cas9 gene editing in 2D and 3D culture models Mol Ther Nucleic Acids. 2024;35(3):102282. doi: https://doi.org/10.1016/j.omtn.2024.102282
Collar AL, Linville AC, Core SB, Frietze KM. Epitope-Based Vaccines against the Chlamydia trachomatis Major Outer Membrane Protein Variable Domain 4 Elicit Protection in Mice. Vaccines (Basel). 2022;10(6):875. doi: https://doi.org/10.3390/vaccines10060875
Poston TB. Advances in vaccine development for Chlamydia trachomatis. Pathog Dis. 2024;82:ftae017. doi: https://doi.org/10.1093/femspd/ftae017
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 L. O. Kovtun

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.